These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 38318069)
1. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension. Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the expression of N6-methyladenosine RNA methylation regulators in pulmonary artery hypertension. Zheng H; Hua J; Li H; He W; Chen X; Ji Y; Li Q Front Genet; 2022; 13():974740. PubMed ID: 36171892 [No Abstract] [Full Text] [Related]
3. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection. Yin F; Liu K; Peng W; Jiang D; Zhang H; Guo P; Wu Y; Zhang X; Sun C; Wang Y; Wang H; Han Y Oxid Med Cell Longev; 2023; 2023():3918393. PubMed ID: 36819785 [TBL] [Abstract][Full Text] [Related]
4. LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation. Wang X; Li Q; He S; Bai J; Ma C; Zhang L; Guan X; Yuan H; Li Y; Zhu X; Mei J; Gao F; Zhu D Mol Med; 2022 Oct; 28(1):126. PubMed ID: 36284300 [TBL] [Abstract][Full Text] [Related]
5. Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export. Qiao Y; Sun Q; Chen X; He L; Wang D; Su R; Xue Y; Sun H; Wang H Elife; 2023 Mar; 12():. PubMed ID: 36892464 [TBL] [Abstract][Full Text] [Related]
6. YTHDC1 aggravates high glucose-induced retinal vascular endothelial cell injury via m6A modification of CDK6. Zhou Q; Tian M; Cao Y; Tang M; Xiang X; Guo L; Lv H Biol Direct; 2024 Jul; 19(1):54. PubMed ID: 38978074 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia activates GPR146 which participates in pulmonary vascular remodeling by promoting pyroptosis of pulmonary artery endothelial cells. Jiang Y; Huang J; Xia Y; Sun Z; Hu P; Wang D; Liu Y; Tao T; Liu Y Eur J Pharmacol; 2023 Feb; 941():175502. PubMed ID: 36638952 [TBL] [Abstract][Full Text] [Related]
8. Investigation into the role of H2-Ab1 in vascular remodeling in pulmonary arterial hypertension via Bioinformatics. Wang G; Wang Z BMC Pulm Med; 2024 Jul; 24(1):342. PubMed ID: 39010027 [TBL] [Abstract][Full Text] [Related]
9. Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis. Wang X; Chen Q; Bing Z; Zhou S; Xu Z; Hou Y; Zhao Y; Zhao S; Wang T Int J Biol Sci; 2023; 19(14):4672-4688. PubMed ID: 37781028 [No Abstract] [Full Text] [Related]
10. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling. Cai D; Chen SY Redox Biol; 2022 Dec; 58():102524. PubMed ID: 36334380 [TBL] [Abstract][Full Text] [Related]
11. Construction and validation of m6A-related diagnostic model for psoriasis. Liu J; Wang Y; Sheng Y; Cai L; Wang Y PeerJ; 2024; 12():e17027. PubMed ID: 38436011 [TBL] [Abstract][Full Text] [Related]
12. SOX17 Prevents Endothelial-Mesenchymal Transition of Pulmonary Arterial Endothelial Cells in Pulmonary Hypertension through Mediating TGF-β/Smad2/3 Signaling. Zou X; Yuan M; Zhou W; Cai A; Cheng Y; Zhan Z; Zhang Y; Pan Z; Hu X; Zhang S; Zheng S; Liu T; Huang P Am J Respir Cell Mol Biol; 2024 Oct; ():. PubMed ID: 39392679 [TBL] [Abstract][Full Text] [Related]
13. Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy. Li Y; Zhang W; Dai Y; Chen K Front Genet; 2022; 13():986995. PubMed ID: 36267414 [No Abstract] [Full Text] [Related]
14. The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression. Jin Z; Liu Y Heliyon; 2023 Sep; 9(9):e19816. PubMed ID: 37809459 [TBL] [Abstract][Full Text] [Related]
15. YTHDC1 maintains trophoblasts function by promoting degradation of m6A-modified circMPP1. Wang D; Guan H; Xia Y Biochem Pharmacol; 2023 Apr; 210():115456. PubMed ID: 36780989 [TBL] [Abstract][Full Text] [Related]
16. METTL3/YTHDC1-medicated m6A modification of circRNA3634 regulates the proliferation and differentiation of antler chondrocytes by miR-124486-5-MAPK1 axis. Song M; Yao H; Sun Z; Chen D; Xu X; Long G; Wu L; Hu W Cell Mol Biol Lett; 2023 Dec; 28(1):101. PubMed ID: 38062349 [TBL] [Abstract][Full Text] [Related]
17. A ring N(CH Kong S; Yu J; Li HF; Xie YL; Song LF; Wang QQ; Chen YJ; Zhao FR; Zhang WF; Zhu TT Eur J Pharmacol; 2023 Nov; 959():176077. PubMed ID: 37820784 [TBL] [Abstract][Full Text] [Related]
18. Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification. Xu X; Shen L; Qu Y; Li D; Zhao X; Wei H; Yue S Sci Rep; 2024 Apr; 14(1):8417. PubMed ID: 38600232 [TBL] [Abstract][Full Text] [Related]
19. YTHDC1 Promotes Stemness Maintenance and Malignant Progression in Head and Neck Squamous Cell Carcinoma. Weng J; Fan H; Liu H; Tang S; Zheng Y Stem Cells Int; 2022; 2022():7494354. PubMed ID: 36411870 [TBL] [Abstract][Full Text] [Related]
20. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension. Wang Z; Yang K; Zheng Q; Zhang C; Tang H; Babicheva A; Jiang Q; Li M; Chen Y; Carr SG; Wu K; Zhang Q; Balistrieri A; Wang C; Song S; Ayon RJ; Desai AA; Black SM; Garcia JGN; Makino A; Yuan JX; Lu W; Wang J Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L216-L228. PubMed ID: 30358436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]